Legend Biotech (LEGN) Interest & Investment Income (2024 - 2025)

Legend Biotech (LEGN) posted Interest & Investment Income of $7.9 million for Q4 2025, down 18.23% on a QoQ basis from $9.7 million in Q3 2025, and down 42.34% year-over-year from $13.7 million in Q4 2024.

Legend Biotech (LEGN) Interest & Investment Income (2024 - 2025) Analysis & Trends

Legend Biotech's Interest & Investment Income history runs 2 years deep, the most recent figure standing at $7.9 million for Q4 2025.

  • Quarterly Interest & Investment Income fell 42.34% year-over-year to $7.9 million in Q4 2025, while the trailing twelve-month figure through Dec 2025 was $40.0 million (down 34.61% YoY) and the FY2025 annual result came in at $40.1 million, down 34.48% from the prior year.
  • Interest & Investment Income was $7.9 million for Q4 2025 at Legend Biotech, down from $9.7 million in the prior quarter.
  • Across five years, Interest & Investment Income topped out at $17.0 million in Q2 2024 and bottomed at $7.9 million in Q4 2025.
Generated on {Timestamp} © BusinessQuant.com
Generated on {Timestamp} Powered by BusinessQuant Logo

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Int & Inv Inc (Qtr)
1 Oculis Holding AG 67,072.09 Bn 67,072.09 Bn - -
2 Nanobiotix 1,894.61 Bn 1,894.55 Bn - -
3 Akari Therapeutics 1,014.18 Bn 1,014.18 Bn - -
4 BeOne Medicines 471.64 Bn 466.85 Bn 1.35 Bn 27.66 Mn
5 Vertex Pharmaceuticals 121.72 Bn 114.47 Bn 2.59 Bn 114.80 Mn
6 Regeneron Pharmaceuticals 68.28 Bn 59.52 Bn 3.31 Bn -65.80 Mn
7 Belite Bio 61.40 Bn 61.40 Bn - -
8 Argenx Se 56.94 Bn 56.94 Bn 1.18 Bn 44.00 Mn
9 Revolution Medicines 37.37 Bn 37.37 Bn - 19.51 Mn
10 Legend Biotech 8.26 Bn 7.36 Bn - 7.90 Mn

Historic Data

Download Data
DateValue
Dec 31, 2025 7.90 Mn
Sep 30, 2025 9.66 Mn
Jun 30, 2025 10.43 Mn
Mar 31, 2025 12.06 Mn
Dec 31, 2024 13.70 Mn
Sep 30, 2024 16.63 Mn
Jun 30, 2024 17.05 Mn
Mar 31, 2024 13.87 Mn